4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000135
EVP, Chief Reg. & Quality Off. sold 530 shares at $475.34 ($251,930)
- EVP, Chief Reg. & Quality Off. gave up 4,962 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −4,962 | $479.61 | $2,379,825 | 59,069 | D |
| 2025-02-27 | Sale : show line 2 in the form 10b5-1 | −530 | $475.34 | $251,930 | 58,539 | D |
| Open-market sales · 530 sh · avg $475.34 · $251,930 | ||||||
Loading xslF345X05/wk-form4_1740779311.xml…